Clinicians’ knowledge and awareness of PROs in immune thrombocytopenia: results of a national survey
Esther Oliva, MD, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy, comments on a national survey conducted in Italy that investigated clinicians’ knowledge and awareness of the importance of patient-reported outcomes (PROs) in immune thrombocytopenia (ITP). Dr Oliva highlights that, unlike many younger physicians, senior hematologists and experienced clinicians recognize the value of PROs in assessing patient well-being and making informed treatment decisions. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
